Global Digital Biomanufacturing Market, by Type (Manufacturing Technologies, Analytical and Process Control Technologies, and Others), by Application (Bioprocess Optimization, Biomanufacturing Process Automation and Control, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 17.92 Bn in 2022 and is expected to exhibit a CAGR of 9.9% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increase in introduction of new technologies and growing pharmaceutical and life science industry is likely to drive the growth of market. Increase in monitoring, data collection and handling, connectivity, computer power, process control algorithms, and automation are the advantages of digital manufacturing. This is contributed to drive the growth of market over the forecast period.
Global Digital Biomanufacturing Market – Impact of Coronavirus (COVID-19) Pandemic
The unexpected breakout of the COVID-19 pandemic has positive impact on the pharmaceutical, biopharmaceutical and life sciences industries. COVID-19 has affected the manufacturing, supply chain etc. Pandemic has influence the biomanufacturing and thus key players are shifted towards digital biomanufacturing. For instance, Merck’s new software suite, Bio4C a data visualization, analytics, and process monitoring platform, supports the digital transformation of biopharmaceutical process development.
Browse 34 Market Data Tables and 27 Figures spread through 202 Pages and in-depth TOC on “Global Digital Biomanufacturing Market”- Forecast to 2030, Global Digital Biomanufacturing Market, by Type (Manufacturing Technologies, Analytical and Process Control Technologies, and Others), by Application (Bioprocess Optimization, Biomanufacturing Process Automation and Control, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in The Global Digital Biomanufacturing Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/digital-biomanufacturing-market-5282
Organizations in the manufacturing sector are under pressure to lower costs, enhance consumer experiences, and boost profitability. With new value propositions, organisations equipped with digital forces are upending established business structures. Manufacturing companies are challenged by this upheaval, but there is also an opportunity for increase in adoption of digital biomanufacturing.
Key Takeaways of the Global Digital Biomanufacturing Market:
- The global digital biomanufacturing market is expected to exhibit a CAGR of 9.9% during the forecast period. Complex regulatory constraints, significant cost pressures, an increasing number of new product classes, and expensive development expenses confront drug makers. These problems are partially being addressed by the development of digital biomanufacturing and thereby drive the growth of market
- Among type, manufacturing technologies segment is expected to exhibit the highest CAGR in the global digital biomanufacturing market over the forecast period. Key players operating in the biopharmaceutical industry are engaged in increase in biologic production. This in turn to drive the growth of segment
- Among application, biomanufacturing process automation and control segment is expected to exhibit higher CAGR in the global digital biomanufacturing Industry inclination towards smart biomanufacturing to improve efficacy and production is anticipated to drive the growth of segment
- Among regions, Asia Pacific is expected to exhibit the highest CAGR in the global digital biomanufacturing market. Expansion of biopharmaceutical and pharmaceutical industry is likely drive the growth of market in region.
- Major players operating in the global digital biomanufacturing market include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare,Culture Biosciences
